Proceedings of the 1st biannual bridging the gaps in lung cancer conference. Read more about Proceedings of the 1st biannual bridging the gaps in lung cancer conference.
Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer. Read more about Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer.
Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series. Read more about Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series.
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains. Read more about HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains.
Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center. Read more about Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center.
Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay. Read more about Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay.
Evaluating Survival After Hospitalization Due to Immune-Related Adverse Events From Checkpoint Inhibitors. Read more about Evaluating Survival After Hospitalization Due to Immune-Related Adverse Events From Checkpoint Inhibitors.
Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both. Read more about Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both.
Quality of Life and Treatment-Related Side Effects in Patients With HR+/HER2- Advanced Breast Cancer: Findings From a Multicountry Survey. Read more about Quality of Life and Treatment-Related Side Effects in Patients With HR+/HER2- Advanced Breast Cancer: Findings From a Multicountry Survey.
Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer. Read more about Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer.
